Overview

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Clinical trial to evaluate the safety and efficacy of JP-1366 in patients with erosive gastroesophageal reflux disease
Phase:
Phase 2
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Esomeprazole